India, Oct. 5 -- AIM ImmunoTech Inc. (AIM) on Monday highlighted recent media coverage of Ampligen (rintatolimod), the company's investigational broad-spectrum antiviral and immunomodulatory therapy. ... Read More
India, Oct. 5 -- Celltrion USA said OMLYCLO (omalizumab-igec), the first and only FDA-approved interchangeable biosimilar to XOLAIR (omalizumab), is now commercially available in the U.S. OMLYCLO is ... Read More
India, Oct. 5 -- RXO, Inc. (RXO) is up 20.53 percent, gaining $4.80 to $28.18 on Monday. The move comes after C.H. Robinson Worldwide and RXO announced a definitive agreement under which C.H. Robinson... Read More
India, Oct. 5 -- Alterity Therapeutics Ltd. (ATHE) reported new analyses from its Phase 2 ATH434-201 trial showing that ATH434 50 mg slowed functional decline in patients with multiple system atrophy ... Read More
India, Oct. 5 -- Sainsbury's held exploratory merger talks with rival Morrisons earlier this year over a potential multibillion-pound deal that could have reshaped the UK supermarket sector, according... Read More
India, Oct. 5 -- German investment company INDUS Holding AG (INH.DE), announced on Monday that it has sold its 100% stake in hydraulic block maker MEWESTA Hydraulik GmbH & Co. KG to Lange Beteiligunge... Read More
India, Oct. 5 -- Alector, Inc. (ALEC) is up 25.69 percent, gaining $0.4650 to $2.2750 on Monday. The move comes after the biotechnology company entered into an exclusive global licensing agreement wit... Read More
India, Oct. 5 -- Alterity Therapeutics Ltd. (ATHE) on Monday announced new analyses from its Phase 2 ATH434-201 trial in multiple system atrophy (MSA), presented at the 2026 International Congress of ... Read More
India, Oct. 5 -- Stocks have moved mostly higher during trading on Monday, extending the upward move seen over the two previous sessions. With the continued advance, the tech-heavy Nasdaq has reached ... Read More
India, Oct. 5 -- On Monday, InTest Corporation (INTT), a global provider of test and process technology solutions, announced estimated revenue and orders for the quarter ended September 30, 2026, alon... Read More